Platelet-rich plasma improves expansion of human mesenchymal stem cells and retains differentiation capacity andin vivobone formation in calcium phosphate ceramics
- 1 January 2006
- journal article
- research article
- Published by Taylor & Francis in Platelets
- Vol. 17 (7) , 462-469
- https://doi.org/10.1080/09537100600758867
Abstract
Introduction: Mesenchymal stem cells (MSC) applied to bone substitution materials can improve bone healing. Bone formation in biocomposites is highly dependent on the kind of biomaterial, its pre-treatment and the applied cells. Potentially immunogenic or infectious supplements such as fetal calf serum (FCS) should be avoided in cell expansion media. Therefore, we developed an expansion protocol free of xenogenic supplements. Cells expanded with two different media were tested on distinct biomaterials for their bone formation capacity after ectopic implantation in vivo, as well as for their growth rate and differentiation capacity in vitro. Methods: MSC of six donors were expanded with cell expansion medium containing FCS (2%) or platelet-rich plasma (PRP, 3%). Their growth rate and osteogenic, adipogenic and chondrogenic differentiation capacity were compared in vitro. For the in vivo bone formation assay, expanded cells (2 × 105 or 2 × 106) were seeded on calcium-deficient hydroxyapatite (CDHA; n = 12) and on β-tricalcium phosphate (β-TCP; n = 12) blocks, which had been coated with either fibronectin or human serum. They were then implanted subcutaneously in severe combined immunodeficient mice (SCID), harvested after 8 weeks and analysed by histology. Bone formation was assessed by a semi-quantitative bone score, after toluidine blue and alizarin red staining. Human cells were detected by an in situ hybridisation for human-specific alu sequences. Results: PRP-supplemented expansion medium yielded two-fold higher cell numbers compared to medium with FCS (P = 0.046) after 3 weeks (four passages) and retained a similar capacity to differentiate towards the osteogenic, chondrogenic and adipogenic lineage. In vivo bone formation was equal for cells expanded with PRP and FCS and depended on the specific surface area of the carrier. CDHA (specific surface area (SSA) 48 m2/g) showed a significantly better bone formation in deep layers (P = 0.005) than β-TCP (SSA 0.5 m2/g). Fibronectin-coating of the ceramics was slightly superior to coating with human serum (P = 0.045). Conclusions: The replacement of FCS by PRP eliminated risks connected with the use of xenogeneic supplements. It improved expansion of MSC and retained their differentiation and in vivo bone formation capacity in a setting adaptable to autogenous use.Keywords
This publication has 15 references indexed in Scilit:
- Ectopic bone formation associated with mesenchymal stem cells in a resorbable calcium deficient hydroxyapatite carrierBiomaterials, 2005
- Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells underin vitroconditionsPlatelets, 2004
- Comparison of platelet, leukocyte, and growth factor levels in point‐of‐care platelet‐enriched plasma, prepared using a modified Curasan kit, with preparations received from a local blood bankClinical Oral Implants Research, 2003
- Platelet-derived growth factors enhance proliferation of human stromal stem cellsBiomaterials, 2003
- Cartilage‐like gene expression in differentiated human stem cell spheroids: A comparison of bone marrow–derived and adipose tissue–derived stromal cellsArthritis & Rheumatism, 2003
- Wachstumsstimulation von humanen osteoblastenähnlichen Zellen durch Thrombozytenkonzentrate in vitroMund-,Kiefer- und Gesichtschirurgie, 2002
- Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cellsBlood, 2001
- BONE FORMATION IN VIVO: COMPARISON OF OSTEOGENESIS BY TRANSPLANTED MOUSE AND HUMAN MARROW STROMAL FIBROBLASTSTransplantation, 1997
- Rapidly Forming Apatitic Mineral in an Osteoblastic Cell Line (UMR 106—01 BSP)Journal of Biological Chemistry, 1995
- Osteogenesis in Marrow-Derived Mesenchymal Cell Porous Ceramic Composites Transplanted Subcutaneously: Effect of Fibronectin and Laminin on Cell Retention and Rate of Osteogenic ExpressionCell Transplantation, 1992